Low-frequency ultrasound sonophoresis to increase the efficiency of topical steroids: A pilot randomized study of humans

International Journal of Pharmaceutics

Volumn 395, Issue 1-2, 2010, Pages 84-90

  Maruani, Annabel ^a,b   Boucaud, Alain ^c   Perrodeau, Elodie ^d   Gendre, David ^d   Giraudeau, Bruno ^a,d   Machet, Laurent ^a,b  

^a UNIVERSITÉ DE TOURS   (France)

^b INSERM   (France)

^c Transderma Systems   (France)

^d UNIVERSITY HOSPITAL OF TOURS   (France)

Author keywords

Clinical study; Low frequency ultrasound; Sonophoresis; Topical steroids

Indexed keywords

BETAMETHASONE VALERATE; STEROID; GLUCOCORTICOID; VASOCONSTRICTOR AGENT;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DEVICE; DRUG EFFICACY; DRUG PENETRATION; DRUG WITHDRAWAL; ECHOGRAPHY; FEMALE; HUMAN; HUMAN EXPERIMENT; LOW FREQUENCY ULTRASOUND SONOPHORESIS; MALE; METHODOLOGY; NORMAL HUMAN; OCCLUSIVE DRESSING; OUTCOME ASSESSMENT; PAIN; PHORESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SKIN PERMEABILITY; TREATMENT OUTCOME; ULTRASOUND; VASOCONSTRICTION; DRUG EFFECTS; FOREARM; FRANCE; INTRADERMAL DRUG ADMINISTRATION; METABOLISM; PERMEABILITY; PILOT STUDY; SKIN; SKIN ABSORPTION; TIME; VASCULARIZATION;

ADMINISTRATION, CUTANEOUS; BETAMETHASONE 17-VALERATE; FOREARM; FRANCE; GLUCOCORTICOIDS; HUMANS; PERMEABILITY; PILOT PROJECTS; SKIN; SKIN ABSORPTION; TIME FACTORS; ULTRASONICS; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; BETAMETHASONE VALERATE;

EID: 77954310057     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.05.010     Document Type: Article

References (21)

1. Becker B.M., Helfrich S., Baker E., Lovgren K., Minugh A., Machan J.T. Ultrasound with topical anesthetic rapidly decreases pain of intravenous cannulation. Acad. Emerg. Med. 2005, 12:289-295.
2. Byl N.N. The use of ultrasound as an enhancer for transcutaneous drug delivery: phonophoresis. Phys. Ther. 1995, 75:539-553.
3. Cevc G., Mazgareanu S., Rother M., Vierl U. Occlusion effect on transcutaneous NSAID delivery from conventional and carrier-based formulations. Int. J. Pharm. 2008, 359:190-197.
4. Katz N.P., Shapiro D.E., Herrmann T.E., Kost J., Custer L.M. Rapid onset of cutaneous anesthesia with EMLA cream after pretreatment with a new ultrasound-emitting device. Anesth. Analg. 2004, 98:371-376.
5. Liu H., Li S., Pan W., Wang Y., Han F., Yao H. Investigation into the potential of low-frequency ultrasound facilitated topical delivery of cyclosporin A. Int. J. Pharm. 2006, 326:32-38.
6. Machet L., Boucaud A. Phonophoresis: efficiency, mechanisms and skin tolerance. Int. J. Pharm. 2002, 243:1-15.
7. Maruani, A., Vierron, E., Machet, L., Giraudeau, B., Halimi, J.M., Boucaud, A. Tolerance of low-frequency ultrasound sonophoresis: a double-blind randomised study on humans. Skin Res. Technol., submitted for publication.
8. Maruani A., Vierron E., Machet L., Giraudeau B., Boucaud A. Efficiency of low-frequency ultrasound sonophoresis in skin penetration of histamine: a randomized study in humans. Int. J. Pharm. 2010, 385:37-41.
9. Mc Kenzie A.W., Stoughton R.B. Method for comparing percutaneous absorption of steroids. Arch. Dermatol. 1962, 86:608-616.
10. Mitragotri S., Kost J. Transdermal delivery of heparin and low-molecular weight heparin using low-frequency ultrasound. Pharm. Res. 2001, 18:1151-1156.
11. Santoianni P., Nino M., Calabro G. Intradermal drug delivery by low frequency sonophoresis (25KHz). Dermatol. Online J. 2004, 10:24.
12. Simonin J.P. On the mechanisms of in vitro and in vivo phonophoresis. J. Control Rel. 1995, 33:125-141.
13. Singer A.J., Homan C.S., Church A.L., McClain S.A. Low-frequency sonophoresis: pathologic and thermal effects in dogs. Acad. Emerg. Med. 1998, 5:35-40.
14. Smith N.B., Lee S., Shung K.K. Ultrasound-mediated transdermal in vivo transport of insulin with low-profile cymbal arrays. Ultrasound Med. Biol. 2003, 29:1205-1210.
15. Tang H., Wang C.C., Blankschtein D., Langer R. An investigation of the role of cavitation in low-frequency ultrasound-mediated transdermal drug transport. Pharm. Res. 2002, 19:1160-1169.
16. Täuber U. Dermocorticosteroids. Structure, activity, pharmacokinetics. Eur. J. Dermatol. 1994, 4:419-429.
17. Tezel A., Sens A., Mitragotri S. Investigations of the role of cavitation in low-frequency sonophoresis using acoustic spectroscopy. J. Pharm. Sci. 2002, 91:444-453.
18. Van den Kerckhove E., Staes F., Flour M., Stappaerts K., Boeckx W. Reproducibility of repeated measurements on healthy skin with Minolta Chromameter CR-300. Skin Res. Technol. 2001, 7:56-59.
19. Weimann L.J., Wu J. Transdermal delivery of poly-l-lysine by sonomacroporation. Ultrasound Med. Biol. 2002, 28:1173-1180.
20. Yamashita N., Tachibana K., Ogawa K., Tsujita N., Tomita A. Scanning electron microscopic evaluation of the skin surface after ultrasound exposure. Anat. Record 1997, 247:455-461.
21. Zderic V., Vaezy S., Martin R.W., Clark J. Ocular drug delivery using 20-kHz ultrasound. Ultrasound Med. Biol. 2002, 28:823-829.